Sundar PichaiSundar Pichai earned $164M in 2023
O

Pravin U. Dugel, M.D.

CEO of Ocular Therapeutix

Education

B.A. from Columbia University in Comparative Literature and Molecular Biology; M.D. from UCLA School of Medicine.

Field of Expertise

Healthcare & Life Sciences - Medicine

Sector of Economy

Healthcare

Born

April 14, 1964 - 61 years ago

CEO of Ocular Therapeutix for

1 year 1 month (Apr 2024 - Present)

Previous Experience

Dr. Dugel previously served as President of IVERIC bio, Inc. and as Executive Vice President, Chief Strategy and Business Officer of IVERIC.

Rivals

Competitors/colleagues of Pravin U. Dugel, M.D.

Holdings

See how much did Pravin U. Dugel, M.D. make over time.

Holdings and trades for CEO of Ocular Therapeutix

Mar 18, 2025

Total Stock Sold

$503.63K

OCUL

$503.63K

63,186 OCUL shares

What if they kept their stock?

If Pravin U. Dugel, M.D. didn't sell their stock, today they would have:
Extra OCUL63,186 shares worth $447.99K.
This is -11.05% and $55.64K less than what they got when they sold the stock.

Insider Trading

See recent insider trades of Pravin U. Dugel, M.D..

OCUL

$186.33K

OCUL at $9.01/share

Nov 25, 2024

Sale

OCUL

$188.34K

OCUL at $9.02/share

Aug 23, 2024

Sale

OCUL

$125.21K

OCUL at $5.79/share

May 23, 2024

Sale

OCUL

854,979 shares

OCUL

Feb 22, 2024

Received

Compensation History

See how much did Pravin U. Dugel, M.D. make over time.

No compensation data available for Pravin U. Dugel, M.D. yet. Come back soon!

Other Ocular Therapeutix CEOs

Here are other CEOs of Ocular Therapeutix